Clinical Trials Directory

Trials / Completed

CompletedNCT05431348

Effect of stRess and exeRcize on the Outcome After Chemo-Radiation

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Glioblastoma (GBM) is a highly malignant, incurable primary brain tumor. Due to the nature of this disease and the extent of the treatment (surgery followed by chemoradiation according to the Stupp trial) patients undergo considerable psychological distress. It is known that stress hormones are involved in a wide range of processes involved in cell survival, cell cycle and immune function, and can cause therapy resistance. In this study the effect of stress on outcome after chemoradiation in patients with GBM will be investigated.

Detailed description

Psychological stress will be measured using multiple approaches; Physiological measures, stress biomarker and questionnaires. Using this approach, a broad insight in the relationship between stress and outcome after chemoradiation will be obtained and the potential influence of physical activity and sleep evaluated. In addition, the results of this study will help to identify patients which experience high stress levels during chemoradiation to pilot (in the future) interventions to reduce stress before and during treatment.

Conditions

Interventions

TypeNameDescription
DEVICESmartwatchPatients will wear the smartwatch during treatment which measures, activity, steps, sleep and heartrate
DIAGNOSTIC_TESTSerum CortisolLevel of cortisol in serum will be determined
OTHERQuestionnairesPatients are asked to fill in patient reported outcomes (PROMS) and specific questions on stress, exercise and fatigue (QSC-R23, IPAQ-SF, MVI-20)

Timeline

Start date
2022-06-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2022-06-24
Last updated
2026-03-04

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05431348. Inclusion in this directory is not an endorsement.